相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Rituximab plus high-dose chemotherapy (MegaCHOEP) or conventional chemotherapy (CHOEP-14) in young, high-risk patients with aggressive B-cell lymphoma: 10-year follow-up of a randomised, open-label, phase 3 trial
Fabian Frontzek et al.
LANCET HAEMATOLOGY (2021)
Outcomes Associated With Thiotepa-Based Conditioning in Patients With Primary Central Nervous System Lymphoma After Autologous Hematopoietic Cell Transplant
Michael Scordo et al.
JAMA ONCOLOGY (2021)
Myeloablative versus non-myeloablative consolidative chemotherapy for newly diagnosed primary central nervous system lymphoma: Results of CALGB 51101 (Alliance).
Tracy Batchelor et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
The relationship among primary anatomic subsite and risk and distribution of second malignant neoplasms in patients with stage I/II diffuse large B-cell lymphoma: An analysis of the surveillance, epidemiology, and end results database
Xuejiao Yin et al.
TRANSLATIONAL ONCOLOGY (2021)
Induction therapy with the MATRix regimen in patients with newly diagnosed primary diffuse large B-cell lymphoma of the central nervous system - an international study of feasibility and efficacy in routine clinical practice
Elisabeth Schorb et al.
BRITISH JOURNAL OF HAEMATOLOGY (2020)
Management and outcome of primary CNS lymphoma in the modern era An LOC network study
Caroline Houillier et al.
NEUROLOGY (2020)
Randomized phase II study of rituximab, methotrexate (MTX), procarbazine, vincristine, and cytarabine (R-MPV-A) with and without low-dose whole-brain radiotherapy (LD-WBRT) for newly diagnosed primary CNS lymphoma (PCNSL).
Antonio Marcilio Padula Omuro et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Radiotherapy or Autologous Stem-Cell Transplantation for Primary CNS Lymphoma in Patients 60 Years of Age and Younger: Results o the Intergroup ANOCEF-GOELAMS Randomized Phase II PRECIS Study
Caroline Houillier et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Rituximab in primary central nervous system lymphoma-A systematic review and meta-analysis
Andreas M. Schmitt et al.
HEMATOLOGICAL ONCOLOGY (2019)
Longitudinal cognitive assessment in patients with primary CNS lymphoma treated with induction chemotherapy followed by reduced-dose whole-brain radiotherapy or autologous stem cell transplantation
Denise D. Correa et al.
JOURNAL OF NEURO-ONCOLOGY (2019)
Rituximab in patients with primary CNS lymphoma (HOVON 105/ALLG NHL 24): a randomised, open-label, phase 3 intergroup study
Jacoline E. C. Bromberg et al.
LANCET ONCOLOGY (2019)
Whole-brain radiotherapy or autologous stem-cell transplantation as consolidation strategies after high-dose methotrexate-based chemoimmunotherapy in patients with primary CNS lymphoma: results of the second randomisation of the International Extranodal Lymphoma Study Group-32 phase 2 trial
Andres J. M. Ferreri et al.
LANCET HAEMATOLOGY (2017)
The role of whole brain radiation in primary CNS lymphoma
Benjamin Kasenda et al.
BLOOD (2016)
The role of autologous stem cell transplantation in primary central nervous system lymphoma
Andres J. M. Ferreri et al.
BLOOD (2016)
High-dose chemotherapy and autologous stem cell transplant compared with conventional chemotherapy for consolidation in newly diagnosed primary CNS lymphoma-a randomized phase III trial (MATRix)
Elisabeth Schorb et al.
BMC CANCER (2016)
Primary CNS lymphoma at first relapse/progression: characteristics, management, and outcome of 256 patients from the French LOC network
Sophie Langner-Lemercier et al.
NEURO-ONCOLOGY (2016)
Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial
Andres J. M. Ferreri et al.
LANCET HAEMATOLOGY (2016)
High-dose chemotherapy with autologous haemopoietic stem cell transplantation for newly diagnosed primary CNS lymphoma: a prospective, single-arm, phase 2 trial
Gerald Illerhaus et al.
Lancet Haematology (2016)
Long-term cognitive function, neuroimaging, and quality of life in primary CNS lymphoma
Nancy D. Doolittle et al.
NEUROLOGY (2013)
Cognitive functions in primary CNS lymphoma after single or combined modality regimens
Denise D. Correa et al.
NEURO-ONCOLOGY (2012)
Cognitive functions in primary central nervous system lymphoma: literature review and assessment guidelines
D. D. Correa et al.
ANNALS OF ONCOLOGY (2007)
Revised response criteria for malignant lymphoma
Bruce D. Cheson et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Results of whole-brain radiation as salvage of methotrexate failure for immunocompetent patients with primary CNS lymphoma
PL Nguyen et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Treatment of relapsed central nervous system lymphoma with high-dose methotrexate
SR Plotkin et al.
CLINICAL CANCER RESEARCH (2004)
分享论文
